Epidemiological features papillomatosis of the larynx in adults: a literature review

Close metadata

Recommended articles:

Epidemiological features of laryngeal papillomatosis in adults in Moscow. Russian Bulletin of Otorhinolaryngology. 2024;(3):4-10

Diagnosis of benign laryngeal tumors using neural network. Russian Bulletin of Otorhinolaryngology. 2024;(3):24-28

Preadolescent acne. Russian Journal of Clinical Dermatology and Venereology. 2024;(2):175-180

Epidemiology of acute poisoning in pediatric practice. Russian Journal of Anesthesiology and Reanimatology. 2024;(2):58-66

Prevalence of cognitive impairment in older adults in the Russian Federation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):5-11

Clinical and epidemiological characteristics of bronchial asthma and chronic obstructive pulmonary disease incidence in Russia before and during the COVID-19 epidemy. Russian Journal of Preventive Medicine. 2024;(6):42-48

Primary prevention of colorectal cancer and technologies for its implementation into practical health care. Russian Journal of Preventive Medicine. 2024;(6):111-117

Medical and economic significance and calculation of economic treatment costs of a patient with hidradenitis suppurativa in the Russian Federation. Russian Journal of Clinical Dermatology and Venereology. 2024;(3):239-244

Association between previous appendectomy and cognitive impairment in adults: a case-control study. Pirogov Russian Journal of Surgery. 2024;(7):73-77

The literature review presents current data on the epidemiology, drug, and surgical treatment of laryngeal papillomatosis in adults. Possible prospects for further study of the prevalence and incidence of the disease and provoking factors of recurrence of the disease for the development of possible preventive measures are considered.

Keywords:

papillomatosis

larynx

epidemiology

Authors:

Kryukov A.I.

Pirogov Russian National Research Medical University;
Sverzhevsky Research Clinical Institute of Otorhinolaryngology

ORCID: 0000-0002-0149-0676

Romanenko S.G.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

SPIN RSCI: 5645-3401
Scopus AuthorID: 14016776700
ORCID: 0000-0002-8202-5505

Oteyami A.B.

Pirogov Russian National Research Medical University

ORCID: 0000-0002-6994-2210

Received:

04.04.2023

Accepted:

12.09.2023

List of references:

Vasilenko YuS. Golos. Foniatricheskie aspekty. M.: Dipak; 2013. (In Russ.).
So RJ, McClellan K, Best SR. Recurrent Respiratory Papillomatosis: Quality of Life Data from an International Patient Registry. The Laryngoscope. 2023;133(8):1919-1926. https://doi.org/10.1002/lary.30401
Soldatskiy YuL. Recurrent respiratory papillomatosis. Voprosy sovremennoj pediatrii. 2007;6(1):69-74. (In Russ.).
Baryshev VV, Andreev VG, Popuchiev VV, Ezhov SV. Modern aspects of studding respiratory papillomatosis. Part 1. Aetiology, pathogenesis, diagnosis. Sibirskij onkologicheskij zhurnal. 2009;35:32-34. (In Russ.).
Shabaldina EV, Pavlenko SA, Shabaldin AV. Recurrent respiratory papillomatosis of larynx. Meditsina Kuzbassa. 2006;3:32-34. (In Russ.).
Omland T, Akre H, Lie KA, Jebsen P, Sandvik L, Brøndbo K. Risk factors for aggressive recurrent respiratory papillomatosis in adults and juveniles. PLoS One. 2014;9(11):e113584. https://doi.org/10.1371/journal.pone.0113584
Rasmussen ER, Schnack DT, Jørkov AS, Raja AA, Olsen CH, Homøe P. Long-term follow-up and outcome in patients with recurrent respiratory laryngeal papillomatosis. Danish Medical Journal. 2017;64(12):A5424.
Ivanchenko GF, Karimova FS. Profilaktika i lechenie papillomatoza gortani. V kn.: Zabolevaniya golosovogo apparata verkhnikh dykhatel’nykh putej. M. 2001:111-113. (In Russ.).
Voznesenskaya IA. Papillomy verkhnikh dykhatel’nykh putej. M.: Meditsina; 1974. (In Russ.).
Degtyareva DV, Polyakov DP, Nazhmudinov II, Ignatova OM, Vavin VV, Guseinov IG, Rabadanova ZR. Prevalence and Etiological Structure of Recurrent Respiratory Papillomatosis in Children and Adults: Actual Data. Otorinolaringologiya. Vostochnaya Evropa. 2022;12(4):433-437. (In Russ.). https://doi.org/10.34883/PI.2022.12.4.028
Mustafaev DM, Egorov VI Epidemiological data on laryngeal papillomatosis in the Moscow region. Nauka i innovatsii v meditsine. 2018;1(9):19-21. (In Russ.). https://doi.org/10.35693/2500-1388-2018-0-1-19-21
Turova IV, Gabdullina AR. Laryngeal Papillomatosis. Nauchnyj meditsinskij vestnik Yugry. 2019;20(2):133-135. (In Russ.). https://doi.org/10.25017/2306-1367-2019-19-2-133-135
Bonagura VR, Hatam LJ, Rosenthal DW, de Voti JA, Lam F, Steinberg BM, Abramson AL. Recurrent respiratory papillomatosis: A complex defect in immune responsiveness to human papillomavirus-6 and -11. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 2010;118(6-7):455-470. https://doi.org/10.1111/j.1600-0463.2010.02617.x
Armstrong LR, Preston EJ, Reichert M, Phillips DL, Nisenbaum R, Todd NW, Jacobs IN, Inglis AF, Manning SC, Reeves WC. Reeves, Incidence and Prevalence of Recurrent Respiratory Papillomatosis among Children in Atlanta and Seattle. Clinical Infectious Diseases. 2000;31(1):107-109. https://doi.org/10.1086/313914
Romanova ZhG, Malets EL. Epidemiological aspects of laryngeal papillomatosis in the adult patients. Vestnik otorinolaringologii. 2013;78(1):22-25. (In Russ.).
Carney S, Psaltis A. Radiofrequency Coblation for the Treatment of Laryngotracheal Papillomas. Otolaryngology — Head and Neck Surgery. 2004;131(2):P137. https://doi.org/10.1016/j.otohns.2004.06.214
Bondaryev A, Makris D, Breen DP, Dutau H. Airway Stenting for Severe Endobronchial Papillomatosis. Respiration. 2009;77(4): 455-458. https://doi.org/10.1159/000134008
Kim HT, Baizhumanova AS. Is recurrent respiratory papillomatosis a manageable or curable disease? Laryngoscope. 2016;126(6): 1359-1364. https://doi.org/10.1002/lary.25795
Ashurov ZM, Zenger VG. Respiratornyj papillomatoz u detej. M.: Media Sphera; 2004. (In Russ.).
Zur Hausen H, de Villiers EM. Human papillomaviruses. Annual Review of Microbiology. 1994;48:427-447. https://doi.org/10.1146/annurev.mi.48.100194.002235
Gómez MA, Drut R, Lojo MM, Drut RM. Detection of human papillomavirus in juvenile laryngeal papillomatosis using polymerase chain reaction. Medicina (B Aires). 1995;55(3):213-217.
Calton CM, Bronnimann MP, Manson AR, Li S, Chapman JA, Suarez-Berumen M, Williamson TR, Molugu SK, Bernal RA, Campos SK. Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosis. PLoS Pathogens. 2017;13(5):e1006200. https://doi.org/10.1371/journal.ppat.1006200
Rautava J, Syrjänen S. Biology of human papillomavirus infections in head and neck carcinogenesis. Head and Neck Pathology. 2012;6(Suppl 1):S3-S15. https://doi.org/10.1007/s12105-012-0367-2
Aaltonen LM, Rihkanen H, Vaheri A. Human papillomavirus in larynx. Laryngoscope. 2002;112(4):700-707. https://doi.org/10.1097/00005537-200204000-00020
Rousseau B, Suehiro A, Echemendia N, Sivasankar M. Raised intensity phonation compromises vocal fold epithelial barrier integrity. Laryngoscope. 2011;121(2):346-351. https://doi.org/10.1002/lary.21364
Sivasankar M, Erickson E, Rosenblatt M, Branski RC. Hypertonic challenge to porcine vocal folds: effects on epithelial barrier function. Otolaryngology — Head and Neck Surgery. 2010;142(1):79-84. https://doi.org/10.1016/j.otohns.2009.09.011
Ruiz R, Achlatis S, Verma A, Born H, Kapadia F, Fang Y, Pitman M, Sulica L, Branski RC, Amin MR. Risk factors for adult-onset recurrent respiratory papillomatosis. The Laryngoscope. 2014;124(10):2338-2344. https://doi.org/10.1002/lary.24730
Born H, Ruiz R, Verma A, Taliercio S, Achlatis S, Pitman M, Gandonu S, Bing R, Amin MR, Branski RC. Concurrent oral human papilloma virus infection in patients with recurrent respiratory papillomatosis: A preliminary study. Laryngoscope. 2014;124(12):2785-2790. https://doi.org/10.1002/lary.24850
Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah KV. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstetrics and Gynecology. 2003;101(4):645-652. https://doi.org/10.1016/s0029-7844(02)03081-8
Kashima HK, Shah F, Lyles A, Glackin R, Muhammad N, Turner L, Van Zandt S, Whitt S, Shah K. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope. 1992;102(1):9-13. https://doi.org/10.1288/00005537-199201000-00002
Kocjan BJ, Gale N, Hočevar Boltežar I, Seme K, Fujs Komloš K, Hošnjak L, Maver PJ, Jelen MM, Zupanič Pajnič I, Balažic J, Poljak M. Identical human papillomavirus (HPV) genomic variants persist in recurrent respiratory papillomatosis for up to 22 years. The Journal of Infectious Diseases. 2013;207(4):583-587. https://doi.org/10.1093/infdis/jis733
Camilleri IG, Milner RH. Human papilloma virus proliferation in a healing burn. Burns. 1996;22(2):162-163. https://doi.org/10.1016/0305-4179(95)00101-8
Carifi M, Napolitano D, Morandi M, Dall’Olio D. Recurrent respiratory papillomatosis: current and future perspectives. Therapeutics and Clinical Risk Management. 2015;11:731-738. https://doi.org/10.2147/TCRM.S81825
Borkowski G, Sommer P, Stark T, Sudhoff H, Luckhaupt H. Recurrent respiratory papillomatosis associated with gastroesophageal reflux disease in children. European Archives of Oto-Rhino-Laryngology. 1999;256(7):370-372. https://doi.org/10.1007/s004050050166
McKenna M, Brodsky L. Extraesophageal acid reflux and recurrent respiratory papilloma in children. International Journal of Pediatric Otorhinolaryngology. 2005;69(5):597-605. https://doi.org/10.1016/j.ijporl.2004.11.021
Rabah R, Lancaster WD, Thomas R, Gregoire L. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatric and Developmental Pathology. 2001;4(1):68-72. https://doi.org/10.1007/s100240010105
Hu L, Benedict PA, Garber D, Wang B, Amin MR, Branski RC. Laryngeal distribution of adult-onset recurrent respiratory papillomatosis: A longitudinal study. Laryngoscope. 2019;129(9):1993-1997. https://doi.org/10.1002/lary.27694
Israr M, Rosenthal D, Frejo-Navarro L, DeVoti J, Meyers C, Bonagura VR. Microarray analysis of human keratinocytes from different anatomic sites reveals site-specific immune signaling and responses to human papillomavirus type 16 transfection. Molecular Medicine. 2018;24(1):23. https://doi.org/10.1186/s10020-018-0022-9
Gerein V, Rastorguev E, Gerein J, Jecker P, Pfister H. Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up. Annals of Otology, Rhinology and Laryngology. 2005;114(6):463-471. https://doi.org/10.1177/000348940511400608
DeVoti JA, Rosenthal DW, Wu R, Abramson AL, Steinberg BM, Bonagura VR. Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: A paired microarray analysis. Molecular Medicine. 2008;14(9-10):608-617. https://doi.org/10.2119/2008-00060.DeVoti
Svistushkin VM, Starostina SV, Egorov VI, Ragimov AA, Mustafaev DM, Matveev AV, Volkova KB. The analysis of the effectiveness of the combined treatment of the patients presenting with laryngeal papillomatosis. Vestnik otorinolaringologii. 2017;82(1):47-51. (In Russ.). https://doi.org/10.17116/otorino201782147-51
Aydin I, Weber S, Snijder B, Samperio Ventayol P, Kühbacher A, Becker M, Day PM, Schiller JT, Kann M, Pelkmans L, Helenius A, Schelhaas M. Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses. PLoS Pathogens. 2014;10(5):e1004162. https://doi.org/10.1371/journal.ppat.1004162
Chow LT, Broker TR, Steinberg BM. The natural history of human papillomavirus infections of the mucosal epithelia. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 2010;118(6-7):422-449. https://doi.org/10.1111/j.1600-0463.2010.02625.x
Remacle M, Eckel HE, eds. Surgery of Larynx and Trachea. M.: BINOM; 2014. (In Russ.).
Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE; Centers for Disease Control and Prevention (CDC). Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR. Morbidity and Mortality Weekly Report. 2015;64(11);300-304.45. https://pubmed.ncbi.nlm.nih.gov/25811679/
Dion GR, Teng S, Boyd LR, Northam A, Mason-Apps C, Vieira D, Amin MR, Branski RC. Adjuvant Human Papillomavirus Vaccination for Secondary Prevention: A Systematic Review. JAMA Otolaryngology — Head and Neck Surgery. 2017;143(6):614-622. https://doi.org/10.1001/jamaoto.2016.4736
Tjon Pian Gi RE, San Giorgi MR, Pawlita M, Michel A, van Hemel BM, Schuuring EM, van den Heuvel ER, van der Laan BF, Dikkers FG. Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis. European Archives of Oto-Rhino-Laryngology. 2016;273(10):3231-3236. https://doi.org/10.1007/s00405-016-4085-3
Matys K, Mallary S, Bautista O, Vuocolo S, Manalastas R, Pitisuttithum P, Saah A. Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccine. Clinical and Vaccine Immunology: CVI. 2012;19(6):881-885. https://doi.org/10.1128/CVI.00002-12
Ivancic R, Iqbal H, deSilva B, Pan Q, Matrka L. Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis. Clinical and Experimental Immunology. 2020;199(2):131-142. https://doi.org/10.1111/cei.13387
Awad R, Shamil E, Aymat-Torrente A, Gibbins N, Harris S. Management of laryngeal papillomatosis using coblation: another option of surgical intervention. European Archives of Oto-Rhino-Laryngology. 2019;276(3):793-800. https://doi.org/10.1007/s00405-019-05354-3

Close metadata